To assess whether Anti-CD26 aAbs were present at baseline in early, treatment-naïve, arthritis patients, we quantified the Ievels of all main isotypes of Anti-CD26 aAbs (IgA, IgG and IgM) in 106 patients at their first visit to the early arthritis clinic. The gene discussed is CD40LG; the disease is arthritic joint disease.